⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7366203 | 0.82 | — | — | |
| SCHEMBL15075 | 0.79 | — | — | |
| SCHEMBL4259471 | 0.79 | CA12 (0.44) | — | |
| SCHEMBL31034365 | 0.76 | CHRM2 (0.53) | — | |
| SCHEMBL4257773 | 0.76 | CA12 (0.50) | — | |
| SCHEMBL1262347 | 0.76 | CHRM2 (0.53) | — | |
| SCHEMBL1218399 | 0.75 | — | — | |
| SCHEMBL8373947 | 0.73 | — | — | |
| Hydrochloric Acid SCHEMBL8984725 | 0.73 | CHRM2 (0.50) | — | |
| Potassium Ion SCHEMBL29196523 | 0.73 | CHRM2 (0.50) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117417265-A | Lipid composition | 富士胶片株式会社 | 2024-01-19 | — | — | CN | disclosed |
| CN-112262122-B | Compound or salt and lipid particle thereof | 富士胶片株式会社 | 2023-10-13 | — | — | CN | disclosed |
| CN-116172975-A | Lipid particle, nucleic acid drug comprising same, and composition for nucleic acid delivery | 富士胶片株式会社 | 2023-05-30 | — | — | CN | disclosed |
| CN-114728016-A | Lipid composition | 富士胶片株式会社 | 2022-07-08 | — | — | CN | disclosed |
| CN-113924128-A | Lipid composition | 富士胶片株式会社 | 2022-01-11 | — | — | CN | disclosed |
| CN-112262122-A | Compound or salt thereof, and lipid particle | 富士胶片株式会社 | 2021-01-22 | — | — | CN | disclosed |
| CN-106414445-A | Compound and application thereof in expansion of hematopoietic stem cells and/or hematopoietic progenitor cells | 蒙特利尔大学 | 2017-02-15 | — | — | CN | disclosed |
| US-6956037-B2 | Benzamide derivatives for the treatment of diseases mediated by cytokines | ASTRAZENECA AB (SE) | 2005-10-18 | — | — | US | disclosed |
| CN-1300278-A | Benzamide derivatives for the treatment of diseases caused by cytokines | ASTRA ZENECA LTD (SE) | 2001-06-20 | — | — | CN | disclosed |
| EP-1077931-A1 | BENZAMIDE DERIVATIVES FOR THE TREATMENT OF DISEASES MEDIATED BY CYTOKINES | AstraZeneca AB (SE) | 2001-02-28 | — | — | EP | disclosed |
| WO-1999059959-A1 | BENZAMIDE DERIVATIVES FOR THE TREATMENT OF DISEASES MEDIATED BY CYTOKINES | ASTRAZENECA AB (SE) | 1999-11-25 | — | — | WO | disclosed |